Page
%P
-
Article
A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease
Short-acting β2-agonist bronchodilators are the most common medications used in treating chronic obstructive pulmonary disease (COPD). Genetic variants determining bronchodilator responsiveness (BDR) in COPD have...